The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Monthly Update

12 Jun 2018 15:09

RNS Number : 1570R
Ranger Direct Lending Fund PLC
12 June 2018
 

12 June 2018

 

Ranger Direct Lending Fund PLC

(The "Company")

MONTHLY UPDATE

The Company announces that the Manager's Monthly Update for 30 April 2018 is now available on its Website at:

 

http://www.rangerdirectlending.uk/newsfeed/

This document is for information purposes only and is not an offer to invest. All investments are subject to risk. Past performance is no guarantee of future returns. Prospective investors are advised to seek expert legal, financial, tax and other professional advice before making any investment decision. The value of investments may fluctuate. Results achieved in the past are no guarantee of future results. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

 

For further information, please contact:

Link Company Matters Limited

+44 (0)1392 477 510

Secretary

Ranger Capital Group

Via Redleaf PR

Bill Kassul

Scott Canon

Liberum Capital Limited

Joshua Hughes

+44 (0)20 3100 2000

Media Enquiries

Redleaf Communications

+ 44 (0) 20 3757 6865

Elisabeth Cowell

ranger@redleafpr.com

Robin Tozer

LEI: 549300VGZSKYQ7C2U221

 

END OF ANNOUNCEMENT

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCGMGMVDZVGRZM

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.